These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 37328279

  • 1. Cause-specific mortality in COPD subpopulations: a cohort study of 339 647 people in England.
    Whittaker H, Rothnie KJ, Quint JK.
    Thorax; 2024 Feb 15; 79(3):202-208. PubMed ID: 37328279
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients.
    Song Q, Zhao YY, Zeng YQ, Liu C, Cheng W, Deng MH, Li X, Ma LB, Chen Y, Cai S, Chen P.
    Int J Chron Obstruct Pulmon Dis; 2021 Feb 15; 16():1401-1412. PubMed ID: 34040367
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of pectoralis muscle area on computed tomography with airflow limitation severity and respiratory outcomes in COPD: A population-based prospective cohort study.
    Zhou K, Wu F, Zhao N, Zheng Y, Deng Z, Yang H, Wen X, Xiao S, Yang C, Chen S, Zhou Y, Ran P, ECOPD study investigators.
    Pulmonology; 2023 Mar 10. PubMed ID: 36907812
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. COPD exacerbations by disease severity in England.
    Merinopoulou E, Raluy-Callado M, Ramagopalan S, MacLachlan S, Khalid JM.
    Int J Chron Obstruct Pulmon Dis; 2016 Mar 10; 11():697-709. PubMed ID: 27099486
    [Abstract] [Full Text] [Related]

  • 9. Comparison of five major airflow limitation criteria to identify high-risk individuals with COPD: a contemporary population-based cohort.
    Çolak Y, Nordestgaard BG, Vestbo J, Lange P, Afzal S.
    Thorax; 2020 Nov 10; 75(11):944-954. PubMed ID: 32820083
    [Abstract] [Full Text] [Related]

  • 10. Association of Medication Intensity and Stages of Airflow Limitation With the Risk of Hospitalization or Death in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
    Lawson CA, Mamas MA, Jones PW, Teece L, McCann G, Khunti K, Kadam UT.
    JAMA Netw Open; 2018 Dec 07; 1(8):e185489. PubMed ID: 30646293
    [Abstract] [Full Text] [Related]

  • 11. Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink.
    Smith MC, Ashdown HF, Sheppard JP, Butler CC, Bankhead C.
    BMJ Open; 2021 Dec 07; 11(12):e050757. PubMed ID: 34876426
    [Abstract] [Full Text] [Related]

  • 12. Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).
    Yang T, Cai B, Cao B, Kang J, Wen F, Chen Y, Jian W, Wang C.
    Ther Adv Respir Dis; 2023 Dec 07; 17():17534666231167353. PubMed ID: 37073797
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
    Wallace AE, Kaila S, Bayer V, Shaikh A, Shinde MU, Willey VJ, Napier MB, Singer JR.
    J Manag Care Spec Pharm; 2019 Feb 07; 25(2):205-217. PubMed ID: 30698096
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
    Janjua S, Mathioudakis AG, Fortescue R, Walker RA, Sharif S, Threapleton CJ, Dias S.
    Cochrane Database Syst Rev; 2021 Jan 15; 1(1):CD013198. PubMed ID: 33448349
    [Abstract] [Full Text] [Related]

  • 18. Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.
    Fraser A, Poole P.
    Cochrane Database Syst Rev; 2022 Nov 14; 11(11):CD013343. PubMed ID: 36373977
    [Abstract] [Full Text] [Related]

  • 19. The effect of airflow limitation on the cause of death in patients with COPD.
    Alfageme I, Reyes N, Merino M, Reina A, Gallego J, Lima J, Palacios Z.
    Chron Respir Dis; 2010 Aug 14; 7(3):135-45. PubMed ID: 20688891
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD Network Registry.
    Kobayashi S, Hanagama M, Ishida M, Sato H, Ono M, Yamanda S, Yamada M, Aizawa H, Yanai M.
    Int J Chron Obstruct Pulmon Dis; 2018 Aug 14; 13():3947-3955. PubMed ID: 30584294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.